Abstract
AbstractOral administration of RNA is currently not possible and current approaches for RNA delivery by injection are not suitable for the oral route. In this work, novel bioinspired nanoparticles for oral delivery of RNA therapies are reported. Specifically, the fabrication of hybrid nanovesicles (“hybridosomes”) based on bovine milk extracellular vesicles (mEVs) and liposomes is reported. Hybridosomes are fabricated using two related methods based on freeze‐thawing of mEVs and cationic liposomes. The systems are 180–230 nm and demonstrated efficient loading of small interfering (siRNA) cargo. Hybridosomes exhibit significantly lower cytotoxicity in intestinal Caco‐2 cells compared to cationic liposomes and superior stability in a fed‐state simulated intestinal fluid compared to liposomes. Furthermore, these systems significantly increase the transport of siRNA across in vitro intestinal model. Finally, hybridosomes loaded with siRNA successfully induce transfection in J774A.1 macrophages. Overall, the results show that the hybrid systems fabricated here offer potential for oral delivery of RNA therapeutics.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
